SCHEMBL29759574

SCHEMBL29759574

Cc1ncc(NC(=O)C[C@@H]2CCN(C(=O)OC(C)(C)C)C2)cc1NC(=O)c1cnn2cc(-c3cnn(C)c3)sc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 1/20 0.40
▸ GLS O94925 5/20 0.38
▸ IRAK1 P51617 1/20 0.38
▸ CSF1R P07333 1/20 0.36
▸ KIT P10721 1/20 0.36
▸ IRAK4 Q9NWZ3 1/20 0.36
▸ MET P08581 1/20 0.35
▸ CETP P11597 1/20 0.35
▸ IDO1 P14902 1/20 0.35
▸ TDO2 P48775 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ KAT8 Q9H7Z6 2/20 0.35
▸ KAT6A Q92794 1/20 0.35
▸ KAT5 Q92993 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ PDGFRA P16234 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29759955 1.00 USP30 (0.40) USP30GLSIRAK1CSF1RKIT
SCHEMBL24579038 1.00 USP30 (0.40) USP30GLSIRAK1CSF1RKIT
SCHEMBL24579089 0.93 KAT6A (0.36) USP30GLSIRAK4CETPIDO1
SCHEMBL24577514 0.93 KAT6A (0.36) USP30GLSIRAK4CETPIDO1
SCHEMBL29759770 0.86 GSK3B (0.38) USP30CSF1RKITGSK3BDYRK1A
SCHEMBL29760106 0.86 GSK3B (0.38) USP30CSF1RKITGSK3BDYRK1A
SCHEMBL24577577 0.86 GSK3B (0.38) USP30CSF1RKITGSK3BDYRK1A
SCHEMBL24577720 0.86 GSK3B (0.38) USP30CSF1RKITGSK3BDYRK1A
SCHEMBL30566605 0.86 GSK3B (0.38) USP30CSF1RKITGSK3BDYRK1A
SCHEMBL27185042 0.86 GSK3B (0.38) USP30CSF1RKITGSK3BDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4267585-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS Actelion Pharmaceuticals Ltd (CH) 2023-11-01 — — EP disclosed
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback